$HWKN

HAWKINS INC

No enriched coverage for $HWKN in the last 7 days.

No SEC Form 4 filings for $HWKN in the last 30 days.

Med

Hawkins (HWKN) Projected to Post Quarterly Earnings on Wednesday

Hawkins (NASDAQ:HWKN) is expected to release its Q4 2026 earnings on Wednesday, May 13th, with analysts projecting earnings of $0.77 per share and revenue of $255.2840 million. The company currently holds a "Hold" consensus rating from analysts, with an average target price of $200.00. Institutional investors have recently adjusted their stakes in the specialty chemicals company.

Hawkins Inc stock (US4202611099): Why its water treatment niche matters more now for steady U.S. gro

Hawkins Inc. specializes in chemical distribution for water treatment and industrial uses, providing a stable investment opportunity due to the non-discretionary nature of water treatment and consistent demand for essential chemicals. The company's strategic focus on the U.S. market, asset-light model, and resilience against economic downturns position it as a reliable pick for investors seeking stability and dividend consistency. Despite potential risks from raw material volatility and regulatory changes, analysts view Hawkins as a steady performer for conservative portfolios.

Hawkins Inc (NASDAQ:HWKN) Reports Q3 Revenue and EPS Miss, Stock Reaction Muted

Hawkins Inc (NASDAQ:HWKN) reported a miss on both Q3 fiscal 2026 revenue and non-GAAP EPS, with figures of $244.1 million and $0.72 respectively, falling short of analyst estimates. Despite the miss, the stock's reaction was muted, showing no significant movement in after-hours trading. The company also declared a regular quarterly cash dividend of $0.19 per share, and investors are now looking towards Q4 and full-year 2026 estimates for future performance.